Chimeric Therapeutics Limited (CHMMF)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
-0.0290 (-96.67%)
At close: Sep 6, 2024
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of $5.25 million as of May 12, 2025. Its market cap has decreased by -68.52% in one year.
Market Cap
5.25M
Enterprise Value
2.00M
Revenue
1.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 74.92M to 5.25M, a decrease of -93.00%. That is a compound annual growth rate of -46.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 5.83M | -14.53% |
Dec 31, 2024 | 6.82M | -60.60% |
Dec 29, 2023 | 17.32M | -27.14% |
Dec 30, 2022 | 23.77M | -62.54% |
Dec 31, 2021 | 63.45M | -15.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.64B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 729.62M |
Tian'an Technology Group | 568.98M |
CytoDyn | 497.14M |
Glass House Brands | 478.11M |
Elite Pharmaceuticals | 468.54M |
Northwest Biotherapeutics | 395.18M |